Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KITE: LPV/r + RAL Switch in HIV
NCT00700115Phase 4Completed
- Sponsor
- Emory University
- Start
- Jun 2008
- Primary completion
- Jan 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of raltegravir in human immunodeficiency virus infection (HIV), sponsored by Emory University. Started Jun 2008; status: completed.
02
Drugs
raltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00700115.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700115.